Suppliers / Zhejiang Jingsheng Pharmaceutical

Zhejiang Jingsheng Pharmaceutical

China Updated 9 July 2026

Zhejiang Jingsheng Pharmaceutical is an API manufacturer based in China. It holds 11 active US drug master files and 3 valid CEPs across a filed portfolio of 10 molecules.

11
active US DMFs
3
valid CEPs
3
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Taizhou, China Not on file
Taizhou City, China Not on file
China, China 3017488372

What they file, and where

Molecule Regulators Docs
Sitagliptin EDQM, US FDA 4
Dapagliflozin US FDA 2
Empagliflozin US FDA 1
Enzalutamide US FDA 1
Ezetimibe US FDA 1
Finerenone US FDA 1
Losartan Potassium EDQM 1
Mirogabalin US FDA 1
Telmisartan US FDA 1
Vonoprazan US FDA 1

Also appears on these molecule pages

Finerenone API Losartan API Sitagliptin API Empagliflozin API Ezetimibe API Telmisartan API Dapagliflozin API Enzalutamide API Vonoprazan API

Questions about Zhejiang Jingsheng Pharmaceutical

Does Zhejiang Jingsheng Pharmaceutical hold a US DMF or a CEP?
Zhejiang Jingsheng Pharmaceutical holds 11 active US drug master files and 3 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Zhejiang Jingsheng Pharmaceutical FDA-registered?
One site operated by Zhejiang Jingsheng Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Zhejiang Jingsheng Pharmaceutical manufacture?
3 registered sites are on record, in China (Taizhou, Taizhou City and China). Every site is listed on this page with the register it came from.
What does Zhejiang Jingsheng Pharmaceutical make?
10 molecules are on record against Zhejiang Jingsheng Pharmaceutical, including Sitagliptin, Dapagliflozin, Empagliflozin and Enzalutamide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Jingsheng Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dr Reddy's Laboratories shares 1 molecule Alivus Life Sciences shares 1 molecule Macleods Pharmaceuticals shares 1 molecule Changzhou Pharmaceutical Factory shares 1 molecule Maithri Drugs shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability